Letter V | page 1 | drug substances index

Valaciclovir

Indicated for: herpes virus infections

J05AB11 Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors

Valdecoxib

Indicated for: pain and inflammation

M01AH03 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Coxibs

Valerian

Indicated for: mild restlessness; minor sleep disorders

N05CXN3 Nervous system | Hypnotics and sedatives | Hypnotics and sedatives in combination, excl. barbiturates

Valerian + lemon balm + mint

Indicated for: mild restlessness; minor sleep disorders

N05CXN3 Nervous system | Hypnotics and sedatives | Hypnotics and sedatives in combination, excl. barbiturates

Valganciclovir

Indicated for: cytomegalovirus infection

J05AB14 Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors

Valproic acid + salts

Indicated for: epilepsy; bipolar disorder

N03AG01 Nervous system | Antiepileptics | Antiepileptics | Fatty acid derivatives

Valsartan

Indicated for: hypertension

C09CA03 Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain

Valsartan + amlodipine

Indicated for: hypertension

C09DB01 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers

Valsartan + hydrochlorothiazide

Indicated for: hypertension

C09DA03 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

Valsartan + indapamide

Indicated for: hypertension

C09DA03 Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

Vamorolone

Indicated for: Duchenne muscular dystrophy

H02AB18 Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids

Vancomycin

Indicated for: bacterial infections

J01XA01 Antiinfectives for systemic use | Other antibacterials | Glycopeptide antibacterials

Vandetanib

Indicated for: cancer

L01EX04 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Vardenafil

Indicated for: erectile dysfunction

G04BE09 Genito urinary system and sex hormones | Urologicals | Urologicals | Drugs used in erectile dysfunction

Varenicline

Indicated for: smoking cessation

N07BA03 Nervous system | Drugs used in addictive disorders | Drugs used in nicotine dependence

Varicella-zoster vaccine (recombinant, adjuvanted)

Indicated for: prevention of herpes zoster

J07BK03 Antiinfectives for systemic use | Viral vaccines | Varicella zoster vaccines

Vasopressin

Indicated for: vasodilatory shock; diabetes insipidus

H01BA01 Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Vasopressin and analogues

Vasopressin (argipressin)

Indicated for: vasodilatory shock; diabetes insipidus

H01BA01 Systemic hormonal preparations, excluding sex hormones and insulins | Posterior pituitary lobe hormones | Vasopressin and analogues

Vecuronium

Indicated for: muscle relaxation in anesthesia

M03AC03 Musculo-skeletal system | Muscle relaxants | Muscle relaxants, peripherally acting agents | Other quaternary ammonium compounds

Vedolizumab

Indicated for: inflammatory bowel disease

L04AG05 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Monoclonal antibodies

Velaglucerase alfa

Indicated for: lysosomal enzyme deficiency

A16AB10 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Velmanase alfa

Indicated for: lysosomal enzyme deficiency

A16AB15 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Vemurafenib

Indicated for: melanoma

L01EC01 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | B-raf serine-threonine kinase (BRAF) inhibitors

Venetoclax

Indicated for: hematologic malignancies

L01XX52 Antineoplastic and immunomodulating agents | Other antineoplastic agents

Venlafaxine

Indicated for: depression; anxiety disorders

N06AX16 Nervous system | Antidepressants | Other antidepressants

Verapamil

Indicated for: hypertension; angina; arrhythmias

C08DA01 Cardiovascular system | Selective calcium channel blockers with direct cardiac effects | Phenylalkylamine derivatives

Verapamil + trandolapril

Indicated for: hypertension

C09BB10 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers

Vernakalant

Indicated for: cardiac arrhythmias

C01BG11 Cardiovascular system | Antiarrhythmics, class I and III | Other antiarrhythmics, class I and III

Verteporfin

Indicated for: macular degeneration; diabetic macular edema

S01LA01 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents

Vestronidase alfa

Indicated for: lysosomal enzyme deficiency

A16AB18 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes

Search for medicines for human use

Index of medicine substances

Valaciclovir

Valdecoxib

Valerian

Valerian + lemon balm + mint

Valganciclovir

Valproic acid + salts

Valsartan

Valsartan + amlodipine

Valsartan + hydrochlorothiazide

Valsartan + indapamide

Vamorolone

Vancomycin

Vandetanib

Vardenafil

Varenicline

Varicella-zoster vaccine (recombinant, adjuvanted)

Vasopressin

Vasopressin (argipressin)

Vecuronium

Vedolizumab

Velaglucerase alfa

Velmanase alfa

Vemurafenib

Venetoclax

Venlafaxine

Verapamil

Verapamil + trandolapril

Vernakalant

Verteporfin

Vestronidase alfa